The effect of isradipine, a new calcium-channel antagonist, in patients with primary Raynaud's phenomenon: A single-blind dose-response study

Verfasser / Beitragende:
[J Leppert, T Jonasson, H Nilsson, I Ringqvist]
Ort, Verlag, Jahr:
1989
Enthalten in:
Cardiovascular Drugs and Therapy, 3/3(1989-05-01), 397-401
Format:
Artikel (online)
ID: 465547362